Recommendations for prevention and control of influenza in children, 2013-2014

Michael T. Brady, Carrie L. Byington, H. Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L Murray, Walter A. Orenstein, Mobeen Rathore, Mark Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, John Bradley, Mary P. Glode, Harry L. Keyserling, Marc A. Fischer, Bruce Gellin, Richard L. Gorman, Lucia Lee & 17 others R. Douglas Pratt, Jennifer S. Read, Joan Robinson, Marco Aurelio Palazzi Safadi, Jane Seward, Jeffrey R. Starke, Geoffrey Simon, Tina Q. Tan, Henry H. Bernstein, David W. Kimberlin, Sarah S. Long, H. Cody Meissner, Stuart T. Weinberg, Jenna A. Katz, Rebecca J. Schneyer, John M. Kelso, Jennifer Frantz

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. Highlights for the upcoming 2013-2014 season include (1) this year's trivalent influenza vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus (same as 2012-2013); an A/Texas/50/2012 (H3N2) virus (antigenically like the 2012-2013 strain); and a B/Massachusetts/2/2012-like virus (a B/Yamagata lineage like 2012-2013 but a different virus); (2) new quadrivalent influenza vaccines with an additional B virus (B/Brisbane/60/2008-like virus [B/Victoria lineage]) have been licensed by the US Food and Drug Administration; (3) annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference); and (4) the dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age is unchanged from 2012-2013. As always, pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

Original languageEnglish (US)
JournalPediatrics
Volume132
Issue number4
DOIs
StatePublished - Oct 1 2013

Fingerprint

Influenza Vaccines
Human Influenza
Cercopithecine Herpesvirus 1
Antiviral Agents
H3N2 Subtype Influenza A Virus
Viruses
Victoria
United States Food and Drug Administration
Infection Control
Health Personnel
Immunization
Vaccines
Nurses
Morbidity
Delivery of Health Care
Mortality
Therapeutics
Infection
Pediatricians

Keywords

  • Children
  • Immunization
  • Inactivated influenza vaccine
  • Influenza
  • Live-attenuated influenza vaccine
  • Pediatrics
  • Vaccine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Brady, M. T., Byington, C. L., Dele Davies, H., Edwards, K. M., Jackson, M. A., Maldonado, Y. A., ... Frantz, J. (2013). Recommendations for prevention and control of influenza in children, 2013-2014. Pediatrics, 132(4). https://doi.org/10.1542/peds.2013-2377

Recommendations for prevention and control of influenza in children, 2013-2014. / Brady, Michael T.; Byington, Carrie L.; Dele Davies, H.; Edwards, Kathryn M.; Jackson, Mary Anne; Maldonado, Yvonne A.; Murray, Dennis L; Orenstein, Walter A.; Rathore, Mobeen; Sawyer, Mark; Schutze, Gordon E.; Willoughby, Rodney E.; Zaoutis, Theoklis E.; Bradley, John; Glode, Mary P.; Keyserling, Harry L.; Fischer, Marc A.; Gellin, Bruce; Gorman, Richard L.; Lee, Lucia; Douglas Pratt, R.; Read, Jennifer S.; Robinson, Joan; Safadi, Marco Aurelio Palazzi; Seward, Jane; Starke, Jeffrey R.; Simon, Geoffrey; Tan, Tina Q.; Bernstein, Henry H.; Kimberlin, David W.; Long, Sarah S.; Cody Meissner, H.; Weinberg, Stuart T.; Katz, Jenna A.; Schneyer, Rebecca J.; Kelso, John M.; Frantz, Jennifer.

In: Pediatrics, Vol. 132, No. 4, 01.10.2013.

Research output: Contribution to journalArticle

Brady, MT, Byington, CL, Dele Davies, H, Edwards, KM, Jackson, MA, Maldonado, YA, Murray, DL, Orenstein, WA, Rathore, M, Sawyer, M, Schutze, GE, Willoughby, RE, Zaoutis, TE, Bradley, J, Glode, MP, Keyserling, HL, Fischer, MA, Gellin, B, Gorman, RL, Lee, L, Douglas Pratt, R, Read, JS, Robinson, J, Safadi, MAP, Seward, J, Starke, JR, Simon, G, Tan, TQ, Bernstein, HH, Kimberlin, DW, Long, SS, Cody Meissner, H, Weinberg, ST, Katz, JA, Schneyer, RJ, Kelso, JM & Frantz, J 2013, 'Recommendations for prevention and control of influenza in children, 2013-2014', Pediatrics, vol. 132, no. 4. https://doi.org/10.1542/peds.2013-2377
Brady MT, Byington CL, Dele Davies H, Edwards KM, Jackson MA, Maldonado YA et al. Recommendations for prevention and control of influenza in children, 2013-2014. Pediatrics. 2013 Oct 1;132(4). https://doi.org/10.1542/peds.2013-2377
Brady, Michael T. ; Byington, Carrie L. ; Dele Davies, H. ; Edwards, Kathryn M. ; Jackson, Mary Anne ; Maldonado, Yvonne A. ; Murray, Dennis L ; Orenstein, Walter A. ; Rathore, Mobeen ; Sawyer, Mark ; Schutze, Gordon E. ; Willoughby, Rodney E. ; Zaoutis, Theoklis E. ; Bradley, John ; Glode, Mary P. ; Keyserling, Harry L. ; Fischer, Marc A. ; Gellin, Bruce ; Gorman, Richard L. ; Lee, Lucia ; Douglas Pratt, R. ; Read, Jennifer S. ; Robinson, Joan ; Safadi, Marco Aurelio Palazzi ; Seward, Jane ; Starke, Jeffrey R. ; Simon, Geoffrey ; Tan, Tina Q. ; Bernstein, Henry H. ; Kimberlin, David W. ; Long, Sarah S. ; Cody Meissner, H. ; Weinberg, Stuart T. ; Katz, Jenna A. ; Schneyer, Rebecca J. ; Kelso, John M. ; Frantz, Jennifer. / Recommendations for prevention and control of influenza in children, 2013-2014. In: Pediatrics. 2013 ; Vol. 132, No. 4.
@article{3501a2bdcfcc47a598628f05e636d24a,
title = "Recommendations for prevention and control of influenza in children, 2013-2014",
abstract = "The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. Highlights for the upcoming 2013-2014 season include (1) this year's trivalent influenza vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus (same as 2012-2013); an A/Texas/50/2012 (H3N2) virus (antigenically like the 2012-2013 strain); and a B/Massachusetts/2/2012-like virus (a B/Yamagata lineage like 2012-2013 but a different virus); (2) new quadrivalent influenza vaccines with an additional B virus (B/Brisbane/60/2008-like virus [B/Victoria lineage]) have been licensed by the US Food and Drug Administration; (3) annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference); and (4) the dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age is unchanged from 2012-2013. As always, pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.",
keywords = "Children, Immunization, Inactivated influenza vaccine, Influenza, Live-attenuated influenza vaccine, Pediatrics, Vaccine",
author = "Brady, {Michael T.} and Byington, {Carrie L.} and {Dele Davies}, H. and Edwards, {Kathryn M.} and Jackson, {Mary Anne} and Maldonado, {Yvonne A.} and Murray, {Dennis L} and Orenstein, {Walter A.} and Mobeen Rathore and Mark Sawyer and Schutze, {Gordon E.} and Willoughby, {Rodney E.} and Zaoutis, {Theoklis E.} and John Bradley and Glode, {Mary P.} and Keyserling, {Harry L.} and Fischer, {Marc A.} and Bruce Gellin and Gorman, {Richard L.} and Lucia Lee and {Douglas Pratt}, R. and Read, {Jennifer S.} and Joan Robinson and Safadi, {Marco Aurelio Palazzi} and Jane Seward and Starke, {Jeffrey R.} and Geoffrey Simon and Tan, {Tina Q.} and Bernstein, {Henry H.} and Kimberlin, {David W.} and Long, {Sarah S.} and {Cody Meissner}, H. and Weinberg, {Stuart T.} and Katz, {Jenna A.} and Schneyer, {Rebecca J.} and Kelso, {John M.} and Jennifer Frantz",
year = "2013",
month = "10",
day = "1",
doi = "10.1542/peds.2013-2377",
language = "English (US)",
volume = "132",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "4",

}

TY - JOUR

T1 - Recommendations for prevention and control of influenza in children, 2013-2014

AU - Brady, Michael T.

AU - Byington, Carrie L.

AU - Dele Davies, H.

AU - Edwards, Kathryn M.

AU - Jackson, Mary Anne

AU - Maldonado, Yvonne A.

AU - Murray, Dennis L

AU - Orenstein, Walter A.

AU - Rathore, Mobeen

AU - Sawyer, Mark

AU - Schutze, Gordon E.

AU - Willoughby, Rodney E.

AU - Zaoutis, Theoklis E.

AU - Bradley, John

AU - Glode, Mary P.

AU - Keyserling, Harry L.

AU - Fischer, Marc A.

AU - Gellin, Bruce

AU - Gorman, Richard L.

AU - Lee, Lucia

AU - Douglas Pratt, R.

AU - Read, Jennifer S.

AU - Robinson, Joan

AU - Safadi, Marco Aurelio Palazzi

AU - Seward, Jane

AU - Starke, Jeffrey R.

AU - Simon, Geoffrey

AU - Tan, Tina Q.

AU - Bernstein, Henry H.

AU - Kimberlin, David W.

AU - Long, Sarah S.

AU - Cody Meissner, H.

AU - Weinberg, Stuart T.

AU - Katz, Jenna A.

AU - Schneyer, Rebecca J.

AU - Kelso, John M.

AU - Frantz, Jennifer

PY - 2013/10/1

Y1 - 2013/10/1

N2 - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. Highlights for the upcoming 2013-2014 season include (1) this year's trivalent influenza vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus (same as 2012-2013); an A/Texas/50/2012 (H3N2) virus (antigenically like the 2012-2013 strain); and a B/Massachusetts/2/2012-like virus (a B/Yamagata lineage like 2012-2013 but a different virus); (2) new quadrivalent influenza vaccines with an additional B virus (B/Brisbane/60/2008-like virus [B/Victoria lineage]) have been licensed by the US Food and Drug Administration; (3) annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference); and (4) the dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age is unchanged from 2012-2013. As always, pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

AB - The purpose of this statement is to update recommendations for routine use of seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. Highlights for the upcoming 2013-2014 season include (1) this year's trivalent influenza vaccine contains an A/California/7/2009 (H1N1) pdm09-like virus (same as 2012-2013); an A/Texas/50/2012 (H3N2) virus (antigenically like the 2012-2013 strain); and a B/Massachusetts/2/2012-like virus (a B/Yamagata lineage like 2012-2013 but a different virus); (2) new quadrivalent influenza vaccines with an additional B virus (B/Brisbane/60/2008-like virus [B/Victoria lineage]) have been licensed by the US Food and Drug Administration; (3) annual universal influenza immunization is indicated with either a trivalent or quadrivalent vaccine (no preference); and (4) the dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age is unchanged from 2012-2013. As always, pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify influenza infections to enable rapid antiviral treatment, when indicated, to reduce morbidity and mortality.

KW - Children

KW - Immunization

KW - Inactivated influenza vaccine

KW - Influenza

KW - Live-attenuated influenza vaccine

KW - Pediatrics

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84885115605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885115605&partnerID=8YFLogxK

U2 - 10.1542/peds.2013-2377

DO - 10.1542/peds.2013-2377

M3 - Article

VL - 132

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 4

ER -